Par Equity

Par Equity LLP is a venture capital firm based in Edinburgh, United Kingdom, specializing in early-stage and growth investments, particularly in the technology sector. Founded in 2008, the firm targets small and medium-sized enterprises (SMEs) with high growth potential, including those in digital health technology. Par Equity primarily invests between £0.25 million and £2.5 million in companies with enterprise values up to £10 million, focusing on opportunities that involve proprietary technology and proven commercial products poised for transatlantic expansion. The firm aims to support Scottish companies looking to enter the United States market while also attracting U.S. businesses to Scotland. Par Equity operates an additional office in San Francisco, California, enhancing its capability to facilitate cross-continental investment opportunities.

Paul Atkinson

Partner

Claire Cramm

Investment Manager

Tom Croy

Investment Director

Aidan MacMillan

Investment Manager

Alastair Moore

Senior Investment Manager

Andrew Noble

Partner

Past deals in Ireland

Red61

Venture Round in 2021
Red61 Limited is a provider of ticketing software and consultancy services, catering to festivals, events, venues, and ticket agencies across the United Kingdom, Australia, Ireland, and Abu Dhabi. Based in Edinburgh, the company offers a range of solutions, including its VIA ticketing system, which efficiently handles high-volume ticket sales for various events and multi-venue networks. Red61 was founded by Tony Davey and Peter McNaught, who sought to address the frustrations within the ticketing industry by fostering long-term, collaborative relationships with their clients. The platform is designed to streamline the ticketing process, making it quick and organized, and supports multiple sales channels such as online, mobile, in-person, and phone sales.

Red61

Seed Round in 2020
Red61 Limited is a provider of ticketing software and consultancy services, catering to festivals, events, venues, and ticket agencies across the United Kingdom, Australia, Ireland, and Abu Dhabi. Based in Edinburgh, the company offers a range of solutions, including its VIA ticketing system, which efficiently handles high-volume ticket sales for various events and multi-venue networks. Red61 was founded by Tony Davey and Peter McNaught, who sought to address the frustrations within the ticketing industry by fostering long-term, collaborative relationships with their clients. The platform is designed to streamline the ticketing process, making it quick and organized, and supports multiple sales channels such as online, mobile, in-person, and phone sales.

Red61

Venture Round in 2020
Red61 Limited is a provider of ticketing software and consultancy services, catering to festivals, events, venues, and ticket agencies across the United Kingdom, Australia, Ireland, and Abu Dhabi. Based in Edinburgh, the company offers a range of solutions, including its VIA ticketing system, which efficiently handles high-volume ticket sales for various events and multi-venue networks. Red61 was founded by Tony Davey and Peter McNaught, who sought to address the frustrations within the ticketing industry by fostering long-term, collaborative relationships with their clients. The platform is designed to streamline the ticketing process, making it quick and organized, and supports multiple sales channels such as online, mobile, in-person, and phone sales.

Red61

Venture Round in 2018
Red61 Limited is a provider of ticketing software and consultancy services, catering to festivals, events, venues, and ticket agencies across the United Kingdom, Australia, Ireland, and Abu Dhabi. Based in Edinburgh, the company offers a range of solutions, including its VIA ticketing system, which efficiently handles high-volume ticket sales for various events and multi-venue networks. Red61 was founded by Tony Davey and Peter McNaught, who sought to address the frustrations within the ticketing industry by fostering long-term, collaborative relationships with their clients. The platform is designed to streamline the ticketing process, making it quick and organized, and supports multiple sales channels such as online, mobile, in-person, and phone sales.

Red61

Seed Round in 2015
Red61 Limited is a provider of ticketing software and consultancy services, catering to festivals, events, venues, and ticket agencies across the United Kingdom, Australia, Ireland, and Abu Dhabi. Based in Edinburgh, the company offers a range of solutions, including its VIA ticketing system, which efficiently handles high-volume ticket sales for various events and multi-venue networks. Red61 was founded by Tony Davey and Peter McNaught, who sought to address the frustrations within the ticketing industry by fostering long-term, collaborative relationships with their clients. The platform is designed to streamline the ticketing process, making it quick and organized, and supports multiple sales channels such as online, mobile, in-person, and phone sales.

Red61

Venture Round in 2015
Red61 Limited is a provider of ticketing software and consultancy services, catering to festivals, events, venues, and ticket agencies across the United Kingdom, Australia, Ireland, and Abu Dhabi. Based in Edinburgh, the company offers a range of solutions, including its VIA ticketing system, which efficiently handles high-volume ticket sales for various events and multi-venue networks. Red61 was founded by Tony Davey and Peter McNaught, who sought to address the frustrations within the ticketing industry by fostering long-term, collaborative relationships with their clients. The platform is designed to streamline the ticketing process, making it quick and organized, and supports multiple sales channels such as online, mobile, in-person, and phone sales.

PathXL

Venture Round in 2015
PathXL, based in Northern Ireland, specializes in digital pathology image analysis and workflow software, as well as educational tools. The company's software is designed to enhance image analysis and streamline workflow management in the pathology and biopharma markets. By facilitating the examination of patient tissue samples, PathXL plays a crucial role in the diagnosis and treatment of various diseases, particularly cancer. Its solutions cater to both research and educational segments, improving diagnostic quality and enabling pathologists to review and share extensive clinical data. Additionally, PathXL's offerings support the development of new therapies and ultimately aim to enhance patient outcomes.

PathXL

Venture Round in 2015
PathXL, based in Northern Ireland, specializes in digital pathology image analysis and workflow software, as well as educational tools. The company's software is designed to enhance image analysis and streamline workflow management in the pathology and biopharma markets. By facilitating the examination of patient tissue samples, PathXL plays a crucial role in the diagnosis and treatment of various diseases, particularly cancer. Its solutions cater to both research and educational segments, improving diagnostic quality and enabling pathologists to review and share extensive clinical data. Additionally, PathXL's offerings support the development of new therapies and ultimately aim to enhance patient outcomes.

PathXL

Venture Round in 2013
PathXL, based in Northern Ireland, specializes in digital pathology image analysis and workflow software, as well as educational tools. The company's software is designed to enhance image analysis and streamline workflow management in the pathology and biopharma markets. By facilitating the examination of patient tissue samples, PathXL plays a crucial role in the diagnosis and treatment of various diseases, particularly cancer. Its solutions cater to both research and educational segments, improving diagnostic quality and enabling pathologists to review and share extensive clinical data. Additionally, PathXL's offerings support the development of new therapies and ultimately aim to enhance patient outcomes.

PathXL

Venture Round in 2013
PathXL, based in Northern Ireland, specializes in digital pathology image analysis and workflow software, as well as educational tools. The company's software is designed to enhance image analysis and streamline workflow management in the pathology and biopharma markets. By facilitating the examination of patient tissue samples, PathXL plays a crucial role in the diagnosis and treatment of various diseases, particularly cancer. Its solutions cater to both research and educational segments, improving diagnostic quality and enabling pathologists to review and share extensive clinical data. Additionally, PathXL's offerings support the development of new therapies and ultimately aim to enhance patient outcomes.

PathXL

Venture Round in 2013
PathXL, based in Northern Ireland, specializes in digital pathology image analysis and workflow software, as well as educational tools. The company's software is designed to enhance image analysis and streamline workflow management in the pathology and biopharma markets. By facilitating the examination of patient tissue samples, PathXL plays a crucial role in the diagnosis and treatment of various diseases, particularly cancer. Its solutions cater to both research and educational segments, improving diagnostic quality and enabling pathologists to review and share extensive clinical data. Additionally, PathXL's offerings support the development of new therapies and ultimately aim to enhance patient outcomes.

Aircraft Medical

Venture Round in 2012
Aircraft Medical Limited develops and produces hand held medical devices. It offers McGRATH, a portable video laryngoscope. The company specializes in anesthesia and critical care products. It markets its products through distribution partners in the United States, Canada, the United Kingdom, Ireland, Italy, France, Denmark, Sweden, Norway, Benelux, and Australasia. Aircraft Medical Limited was formerly known as Smartscope MD Ltd. and changed its name to Aircraft Medical Limited in February 2004. The company was founded in 2001 and is based in Edinburgh, the United Kingdom. As of November 18, 2015, Aircraft Medical Limited operates as a subsidiary of Medtronic plc.

PathXL

Venture Round in 2012
PathXL, based in Northern Ireland, specializes in digital pathology image analysis and workflow software, as well as educational tools. The company's software is designed to enhance image analysis and streamline workflow management in the pathology and biopharma markets. By facilitating the examination of patient tissue samples, PathXL plays a crucial role in the diagnosis and treatment of various diseases, particularly cancer. Its solutions cater to both research and educational segments, improving diagnostic quality and enabling pathologists to review and share extensive clinical data. Additionally, PathXL's offerings support the development of new therapies and ultimately aim to enhance patient outcomes.

PathXL

Venture Round in 2012
PathXL, based in Northern Ireland, specializes in digital pathology image analysis and workflow software, as well as educational tools. The company's software is designed to enhance image analysis and streamline workflow management in the pathology and biopharma markets. By facilitating the examination of patient tissue samples, PathXL plays a crucial role in the diagnosis and treatment of various diseases, particularly cancer. Its solutions cater to both research and educational segments, improving diagnostic quality and enabling pathologists to review and share extensive clinical data. Additionally, PathXL's offerings support the development of new therapies and ultimately aim to enhance patient outcomes.

Flightman

Venture Round in 2011
Flightman is a developer of an electronic flight bag software used to integrate the aircraft within the Enterprise IT infrastructure. The company provides Electronic Flight Bag software applications. Its software provides a directional exchange of data with the airline's back-office systems and allows the airline to combine user assigned devices together with aircraft devices as well as provide optimized regulatory compliance and total operational efficiency. Flightman’s Solution Suite allows airlines to achieve optimized regulatory compliance, total operational efficiency, and enhanced in-cabin passenger service and revenue opportunities by seamlessly connecting and integrating the aircraft within the Enterprise IT infrastructure. The company also develops Aviation Software Applications which are incorporated in a Service to connect the aircraft to company systems and drive productivity and operational improvements.

Aircraft Medical

Venture Round in 2011
Aircraft Medical Limited develops and produces hand held medical devices. It offers McGRATH, a portable video laryngoscope. The company specializes in anesthesia and critical care products. It markets its products through distribution partners in the United States, Canada, the United Kingdom, Ireland, Italy, France, Denmark, Sweden, Norway, Benelux, and Australasia. Aircraft Medical Limited was formerly known as Smartscope MD Ltd. and changed its name to Aircraft Medical Limited in February 2004. The company was founded in 2001 and is based in Edinburgh, the United Kingdom. As of November 18, 2015, Aircraft Medical Limited operates as a subsidiary of Medtronic plc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.